Clinical Trials: Platelet Aggregation Inhibitors
- Abciximab 57 studies
- Acetylsalicylic acid lysinate 4 studies
- Anagrelide 14 studies
- Andrographolide 1 study
- Argatroban 14 studies
- Aspirin, dipyridamole drug combination 11 studies
- Beraprost 10 studies
- Cilostazol 69 studies
- Clopidogrel 390 studies
- Defibrotide 8 studies
- Eicosapentaenoic acid ethyl ester 7 studies
- Eptifibatide 23 studies
- Essential 303 forte 1 study
- Ibudilast 4 studies
- Ifetroban 1 study
- Indobufen 2 studies
- N,N-diethyl-2-((4-phenylmethyl)phenoxy)ethanamine 2 studies
- Naftopidil 2 studies
- Nitroaspirin 3 studies
- Policosanol 13 studies
- Pycnogenols 8 studies
- Ramatroban 1 study
- Resveratrol 44 studies
- Rosmarinic acid 2 studies
- Sarpogrelate 7 studies
- Sevoflurane 171 studies
- SR 46349B 7 studies
- Tirofiban 24 studies
- Tranilast 9 studies
- Triflusal 2 studies
- 3,4-dihydroxyphenylethanol 1 study
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/browse/intr_cat_PlAggInh
